Q2 2012

Dr. Reddy's Q2 Profit Jumps on New Drugs

Sinopec Sees Rising Demand in Second Half

PetroChina Plans Overseas Investments while Q2 profit slides

Merck KGaA Beats in Q2 on Rebif Drug

Oxea Reports Robust Earnings and Strong Cash Flows

Oxea, a global supplier of Oxo Intermediates and Oxo Derivatives, today announced robust earnings for the second quarter of 2012, with net sales of €380 million getting close to prior year's level.

Brenntag Grows in Q2 2012 in More Difficult Market Conditions

Argentina's YPF Says Q2 Net Profit Up 8%

Novo Nordisk Raises Targets on Victoza, Insulin Demand

Petrobras Posts First Loss in 13 Years

Fresenius May Lift Outlook Again on Rivals' Shortages

Chemtura Reports Second Quarter 2012 Financial Results

Huntsman Results Beat on Demand for Polyurethane Foam

Life Tech Reins in 2012 Forecast

Pfizer Beats Forecasts, Helped by Cost Cuts

Bayer Lifts 2012 Outlook on Pesticides

Strong Merck & Co Results Boost Faith as Generics Loom

Cheap Shale Gas Helps LyondellBasell Beat Estimates

Chevron Profit Slips, but Refineries Shine

Solvay Offsets PVC Problems and Performs Well in Second Quarter

Amgen Q2 Profit Beats Estimates

ExxonMobil Profit Lower than Expexted

BG Looks to Long Term after Quarterly Setbacks

Shell Results Kick Off Weak Quarter for Oil Majors

ConocoPhillips, Hess Profits Drop as Oil Prices Weaken

Sick Europe Forces GSK to Cut 2012 Sales Outlook

Wacker's Sales and Earnings Grow in Q2 2012

Biogen Q2 Profit Up on MS Drug Sales

Citing Global Anxiety, DuPont Gets Cautious on 2012

Novartis on Track despite Bigger Dollar Hit

AkzoNobel Second Quarter Revenue Up

Abbott Sticks to 2012 View, Despite Stronger Dollar

Saudi Basic Industries Q2 Profits Fall 35%